• Je něco špatně v tomto záznamu ?

The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics

D. Vejrazkova, M. Vankova, J. Vcelak, H. Krejci, K. Anderlova, A. Tura, G. Pacini, A. Sumova, M. Sladek, B. Bendlova

. 2022 ; 13 (-) : 868364. [pub] 20220606

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018054

Background: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. Results: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. Conclusion: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018054
003      
CZ-PrNML
005      
20220804134527.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2022.868364 $2 doi
035    __
$a (PubMed)35733780
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Vejrazkova, Daniela $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
245    14
$a The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics / $c D. Vejrazkova, M. Vankova, J. Vcelak, H. Krejci, K. Anderlova, A. Tura, G. Pacini, A. Sumova, M. Sladek, B. Bendlova
520    9_
$a Background: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. Results: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. Conclusion: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals.
650    _2
$a krevní glukóza $7 D001786
650    _2
$a C-peptid $7 D002096
650    12
$a diabetes mellitus 2. typu $x epidemiologie $x genetika $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glukagon $7 D005934
650    _2
$a glukosa $7 D005947
650    12
$a porucha glukózové tolerance $x epidemiologie $x genetika $7 D018149
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $7 D007328
650    12
$a inzulinová rezistence $x genetika $7 D007333
650    _2
$a kinetika $7 D007700
650    _2
$a mužské pohlaví $7 D008297
650    12
$a prediabetes $7 D011236
650    12
$a receptor melatoninový MT2 $x genetika $7 D044123
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vankova, Marketa $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
700    1_
$a Vcelak, Josef $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
700    1_
$a Krejci, Hana $u Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Anderlova, Katerina $u Department of Obstetrics and Gynecology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
700    1_
$a Tura, Andrea $u Metabolic Unit, Institute of Neuroscience, National Research Council, Padova, Italy
700    1_
$a Pacini, Giovanni $u Metabolic Unit, Institute of Neuroscience, National Research Council, Padova, Italy
700    1_
$a Sumova, Alena $u Laboratory of Biological Rhythms, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Sladek, Martin $u Laboratory of Biological Rhythms, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Bendlova, Bela $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czechia
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 13, č. - (2022), s. 868364
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35733780 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134521 $b ABA008
999    __
$a ok $b bmc $g 1821899 $s 1169297
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 13 $c - $d 868364 $e 20220606 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...